99
Participants
Start Date
February 28, 2015
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2021
18F-FCH PET/MRI Scan
Patients will first undergo screening to ensure eligibility. If eligible, they will undergo a PET/MRI scan using 18F-FCH as the radiolabeled tracer. If prostate cancer is detected outside the prostate, patients may undergo a biopsy or follow-up 18F-FCH PET/MRI to confirm the results.
St. Vincent's Hospital, Sydney
Peter MacCallum Cancer Centre, Melbourne
Austin Hospital, Melbourne
Eastern Health, Melbourne
Lawson Health Research Institute, London Health Sciences Centre, London
University of Toronto, Toronto
Universite Laval Quebec, Laval
Velindre Cancer Centre, Cardiff
University College London Hospital, London
Royal Marsden Hospital, London
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER